The Celgene Story Is Bigger Than Revlimid Now; Argus Upgrades
July 31, 2017 at 12:35 PM EDT
Argus upgraded Celgene Corporation (NASDAQ: CELG) Monday on the strength of a diversified drug portfolio and a “robust development ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.